Fadlo R. Khuri is President of the American University of Beirut (AUB) and an internationally recognized oncologist. During his presidency, he has led AUB through successive national crises, including Lebanon’s economic collapse, the Beirut port explosion, the COVID-19 pandemic, and the 2023–24 war, while strengthening the university’s global standing as a mission-driven academic health institution. He also oversaw the acquisition of AUB’s first community hospital and major health system modernization, including adoption of EPIC and entry into the COSMOS research consortium, the first outside the United States.
An internationally recognized oncologist, Dr. Khuri previously held endowed chairs at Emory University, served on faculty at MD Anderson Cancer Center, and was Editor-in-Chief of Cancer from 2011 to 2021. In Lebanon, he strengthened national cancer guidelines and advanced tobacco-control policy. He has chaired NIH oncology study sections and served on review committees for ASCO, ACS, and NCI. His honors include the AACR Rosenthal Award, WHO No Tobacco Award, IASLC Joseph W. Cullen Award, and election to the American Academy of Arts and Sciences (2025).
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
